Oxford, England, United Kingdom · On-site
NIOX® is a medical device company focused on point of care asthma diagnosis and management. Our market-leading NIOX® products are used in clinical settings by physicians around the world to improve asthma diagnosis and m…
Skills: Campaign Planning, Content Creation, Digital Marketing, Email Marketing, Regulatory Compliance
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
The Marketing Executive is responsible for planning and executing integrated marketing campaigns to drive brand awareness and product adoption. This includes creating scientifically accurate content, managing digital channels, and ensuring all materials comply with healthcare regulatory guidelines.
The candidate must be able to coordinate complex project timelines and collaborate with external agencies and internal stakeholders. Experience in managing promotional material reviews (PMRC) and tracking campaign performance via analytics is essential.
NIOX® is a medical device company focused on point of care asthma diagnosis and management. Our market-leading NIOX® products are used in clinical settings by physicians around the world to improve asthma diagnosis and management and by leading research organisations conducting clinical studies on behalf of pharmaceutical companies. At present, NIOX® provides products and services in around 50 countries. For more information please visit www.NIOX®.com.
In order to support these activities, we are currently seeking a Marketing Executive.
Reporting into the Medical Marketing Manager, the Marketing Executive is responsible for the planning, coordination, and execution of marketing campaigns to drive brand awareness, customer engagement, and product adoption.
Following the brief of the Medical Marketing Manager, this role focuses on developing and implementing tactical marketing activities, managing content creation, and ensuring consistent messaging across all channels.
The Marketing Executive plays a vital role in delivering campaigns on time and within budget while upholding regulatory compliance in a healthcare and pharmaceutical environment.
In collaboration with the Medical Marketing Manager and Regional Brand Leads, the Marketing Executive will develop digital and email campaigns - optimising, tracking and reporting on performance.
As a medical devices company, the Marketing Executive will also take ownership of the submitting materials to the companies Promotional Material Review Committee (PMRC) to ensure that all campaigns are adherent to industry guidelines and regulations.
Key Responsibilities of Role:
· Collaborate and assist in the development and delivery of integrated marketing campaigns across digital, print, and event platforms.
· Coordinate timelines, resources, and stakeholders to ensure projects are executed effectively.
· Support product launches by preparing marketing materials and coordinating roll-out activities.
· Maintain brand consistency across all marketing communications.
· Produce engaging and scientifically accurate marketing content, including brochures, presentations, website copy, and social media posts.
· Work with external agencies, designers, and suppliers to develop marketing collateral.
· Update and maintain the company website, social media channels, and digital assets library.
· Responsible for the creation, publication, and scheduling of social media posts
· Organize and manage logistics for trade shows, medical conferences, symposia, and webinars.
· Coordinate with internal teams and external vendors to ensure successful event delivery.
· Gather and report on post-event feedback and analytics to improve future activities.
· Conduct competitor and market analysis to support campaign planning and product positioning.
· Collect and interpret customer feedback to guide marketing initiatives.
· Provide insights to senior marketing colleagues for strategy development.
· Track and report on campaign performance using analytics tools.
· Maintain marketing databases, CRM systems, and distribution lists.
· Manage purchase orders, invoices, and budget tracking in coordination with the finance team.
· Responsible for execution of the companies press strategy
Office Location
This position will be based out of our Oxford Global head Office.
Culture
NIOX® is proud to be an inclusive employer that supports all colleagues to realise and achieve their full potential. We are a diverse organization that champions a healthy work life balance.
As a truly global organization, international collaboration between colleagues in different countries is encouraged and supported.
We live and breathe our PRIDE values and ensure that we are all working towards a common goal and this is to improve the quality of life of millions of people suffering from asthma.
We value the contribution that each of our colleagues provide and recognize the difference they make to the lives of asthma sufferers every day by supporting us in working towards our goal.
Application process
Thank you for considering a career at NIOX®. If you would like to apply for the position, please apply online, ensuring you include the following information:
· Full name, location, email address and phone number
· Curriculum Vitae
· Cover letter
· Current salary
· Required salary
· Date available to start/notice period
After you have submitted this information, an email will be sent to you inviting you for a first interview. Due to the quantity of applications we receive, if you do not receive an email from us within 10 working days, please assume that you have been unsuccessful on this occasion.
Important notice to Employment businesses/ Agencies
NIOX® does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact NIOX®’s human resources department to obtain prior written authorisation before referring any candidates to NIOX®. The obtaining of prior written authorisation is a condition precedent to any agreement (verbal or written) between the employment business/ agency and NIOX®. In the absence of such written authorisation being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of NIOX®. NIOX® shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.
NIOX Group plc is a dedicated diagnostics and monitoring company focused on respiratory disease.
NIOX Group plc is a company that specialises in the development, manufacture, and distribution of medical devices for the diagnosis and monitoring of asthma. Their flagship product, NIOX VERO®, is a non-invasive medical device that measures fractional exhaled nitric oxide (FeNO) levels in patients with asthma. NIOX VERO® provides accurate and reliable results, allowing healthcare professionals to make informed decisions about the diagnosis and management of asthma. It is easy to use, and can be used in a variety of settings, including clinics, hospitals, and primary care settings. The NIOX Group plc is committed to improving the lives of people with asthma and is dedicated to innovation and excellence in its products and services. NIOX® is also committed to offering additional training and support for healthcare professionals. Overall, NIOX Group plc is the global leader in FeNO testing, with a strong reputation for innovation and excellence in the development of medical devices for the diagnosis and management of asthma. With NIOX VERO®, healthcare professionals have a reliable and non-invasive tool to help them better diagnose and manage asthma. References: 1. Alving K et al. Validation of a new portable exhaled nitric oxide analyzer, NIOX VERO®: randomized studies in asthma. Pulm Ther. 2017;3:207-218. 2. Gao J et al. Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma. Allergy, Asthma & Clinical Immunology. 2018;1 3. Busse WW et al. Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis. Lancet Respir Med. 2021;9(10):1165-1173. 4. Menzies-Gow A et al. Clinical utility of fractional exhaled nitric oxide in severe asthma management. Eur Respir J. 2020;55(3):1901633. 5. NIOX®. Data on File; MKT-DOF-007.
Offices: Edmund Halley Road, Oxford, England OX4 4GB, GB · Hansellisgatan, Uppsala, Uppsala County 754 50, SE · Jing Guang Centre Office Building, Room 608, No.1 Chao Yang Men Wai Avenue, Hu Jia Lou, Chao Yang District, Beijing, 100020, CN · Louisenstraße 21, Bad Homburg, 61348, DE · 5151 McCrimmon Pkwy, Morrisville, North Carolina 27560, US
NIOX Group plc is a dedicated diagnostics and monitoring company focused on respiratory disease.
NIOX Group plc is a company that specialises in the development, manufacture, and distribution of medical devices for the diagnosis and monitoring of asthma. Their flagship product, NIOX VERO®, is a non-invasive medical device that measures fractional exhaled nitric oxide (FeNO) levels in patients with asthma. NIOX VERO® provides accurate and reliable results, allowing healthcare professionals to make informed decisions about the diagnosis and management of asthma. It is easy to use, and can be used in a variety of settings, including clinics, hospitals, and primary care settings. The NIOX Group plc is committed to improving the lives of people with asthma and is dedicated to innovation and excellence in its products and services. NIOX® is also committed to offering additional training and support for healthcare professionals. Overall, NIOX Group plc is the global leader in FeNO testing, with a strong reputation for innovation and excellence in the development of medical devices for the diagnosis and management of asthma. With NIOX VERO®, healthcare professionals have a reliable and non-invasive tool to help them better diagnose and manage asthma. References: 1. Alving K et al. Validation of a new portable exhaled nitric oxide analyzer, NIOX VERO®: randomized studies in asthma. Pulm Ther. 2017;3:207-218. 2. Gao J et al. Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma. Allergy, Asthma & Clinical Immunology. 2018;1 3. Busse WW et al. Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis. Lancet Respir Med. 2021;9(10):1165-1173. 4. Menzies-Gow A et al. Clinical utility of fractional exhaled nitric oxide in severe asthma management. Eur Respir J. 2020;55(3):1901633. 5. NIOX®. Data on File; MKT-DOF-007.
Offices: Edmund Halley Road, Oxford, England OX4 4GB, GB · Hansellisgatan, Uppsala, Uppsala County 754 50, SE · Jing Guang Centre Office Building, Room 608, No.1 Chao Yang Men Wai Avenue, Hu Jia Lou, Chao Yang District, Beijing, 100020, CN · Louisenstraße 21, Bad Homburg, 61348, DE · 5151 McCrimmon Pkwy, Morrisville, North Carolina 27560, US
